List of Excipients in API diroximel fumarate
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing diroximel fumarate
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Biogen Inc | VUMERITY | diroximel fumarate | 64406-020 | CARRAGEENAN | |
| Biogen Inc | VUMERITY | diroximel fumarate | 64406-020 | CELLULOSE, MICROCRYSTALLINE | |
| Biogen Inc | VUMERITY | diroximel fumarate | 64406-020 | CROSPOVIDONE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for diroximel fumarate
Excipient focus: CARRAGEENAN
diroximel fumarate drug variants containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| Biogen Inc | diroximel fumarate | 64406-020 |
| >Company | >Ingredient | >NDC |
diroximel fumarate drug variants not containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
diroximel fumarate drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Biogen Inc | diroximel fumarate | 64406-020 |
| >Company | >Ingredient | >NDC |
diroximel fumarate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
diroximel fumarate drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Biogen Inc | diroximel fumarate | 64406-020 |
| >Company | >Ingredient | >NDC |
diroximel fumarate drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
diroximel fumarate drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Biogen Inc | diroximel fumarate | 64406-020 |
| >Company | >Ingredient | >NDC |
diroximel fumarate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
diroximel fumarate drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Biogen Inc | diroximel fumarate | 64406-020 |
| >Company | >Ingredient | >NDC |
diroximel fumarate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
diroximel fumarate drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Biogen Inc | diroximel fumarate | 64406-020 |
| >Company | >Ingredient | >NDC |
diroximel fumarate drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM CHLORIDE
diroximel fumarate drug variants containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| Biogen Inc | diroximel fumarate | 64406-020 |
| >Company | >Ingredient | >NDC |
diroximel fumarate drug variants not containing POTASSIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
diroximel fumarate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Biogen Inc | diroximel fumarate | 64406-020 |
| >Company | >Ingredient | >NDC |
diroximel fumarate drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
diroximel fumarate drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Biogen Inc | diroximel fumarate | 64406-020 |
| >Company | >Ingredient | >NDC |
diroximel fumarate drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
diroximel fumarate drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Biogen Inc | diroximel fumarate | 64406-020 |
| >Company | >Ingredient | >NDC |
diroximel fumarate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
diroximel fumarate drug variants containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Biogen Inc | diroximel fumarate | 64406-020 |
| >Company | >Ingredient | >NDC |
diroximel fumarate drug variants not containing TRIETHYL CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch